Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qinghua Xiaoyong Fang (清化消痈方) is a traditional Chinese medicine (TCM) herbal formula. It is used primarily for the treatment of perianal fistula in Crohn's disease patients with a TCM diagnosis of "dampness-heat diffusing downward." The formula is designed to clear heat, resolve toxicity, reduce swelling, and promote healing of abscesses and fistulas. Its mechanism involves anti-inflammatory effects, immune modulation, and possibly antibacterial actions typical of TCM formulas aimed at "clearing heat" and "resolving toxins." Clinical studies have evaluated its efficacy in reducing symptoms such as pain, discharge, and inflammation associated with perianal fistulas[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qinghua Xiaoyong Fang.